Medicure Inc
Company Profile
Business description
Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.
Contact
2 - 1250 Waverley Street
WinnipegMBR3T 6C6
CANT: +1 204 487-7412
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
25
Stocks News & Analysis
stocks
Are investors missing the boat on this future ASX leader?
stocks
ASX shares plunge but remain undervalued
stocks
Ask the analyst: Why have markets shunned APA Group?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,494.30 | 22.50 | 0.27% |
CAC 40 | 7,423.67 | 15.03 | 0.20% |
DAX 40 | 20,271.33 | 138.48 | 0.69% |
Dow JONES (US) | 42,518.28 | 221.16 | 0.52% |
FTSE 100 | 8,201.54 | 22.65 | -0.28% |
HKSE | 19,219.78 | 345.64 | 1.83% |
NASDAQ | 19,044.39 | 43.71 | -0.23% |
Nikkei 225 | 38,474.30 | 716.10 | -1.83% |
NZX 50 Index | 12,902.69 | 18.31 | 0.14% |
S&P 500 | 5,842.91 | 6.69 | 0.11% |
S&P/ASX 200 | 8,251.80 | 20.80 | 0.25% |
SSE Composite Index | 3,240.94 | 80.19 | 2.54% |